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XBP-1 image overhaul
 
The development of antibody-secreting plasma cells is crippled
in the absence of the transcription factor XBP-1 (X-box
binding protein). Based on the role of XBP-1 in the endo-
plasmic reticulum (ER) unfolded protein response (UPR),
it was speculated that the ER needs this protein to cope with
the ramped-up protein production that accompanies plasma
cell differentiation. On page 505, Tirosh and coworkers
show instead that XBP-1 controls immunoglobulin synthe-
sis posttranslationally, independently of its role in orches-
trating the UPR.
The UPR is a signaling system that ensures proper fold-
ing, processing, and degradation of proteins in the ER.
When protein production exceeds the ER’s quality control
capacity, XBP-1 drives the expression of additional proteins,
such as chaperones and degradative enzymes that help to
absorb the extra workload.
The prevailing explanation for the XBP-1 requirement
in plasma cell development—that the ER otherwise becomes
lethally clogged with excess immunoglobulin protein—is
called into question by the new data from Ploegh’s group.
The study shows that protein degradation in the ER was
intact in the absence of XBP-1, suggesting that the ER
quality control pathway in B cells does not require XBP-1.
Instead, XBP-1 was required for the sustained synthesis of
IgM in primary B cells. This defect was specific for IgM
heavy chain protein, as synthesis and trafficking of other
proteins were unaffected.
 
Water-clogging antibodies
 
Autoantibodies produced during a severe 
variant of multiple sclerosis (MS) latch on to 
water channels in the brain, according to 
Lennon and colleagues on page 473.
Optic–spinal MS (or neuromyelitis 
optica, NMO) is a severe demyelinating 
disease that affects the spinal cord and 
optic nerves and is often misdiagnosed as 
classical MS, despite the absence of typical 
MS-like brain lesions. This group recently 
described an antibody that was present in 
the serum of up to 70% of patients with 
NMO, but was never found in patients with 
classical MS. The antibody bound to an 
unidentified antigen prominent at the 
blood–brain barrier.
Lennon and her colleagues now 
identify the target of the antibody as 
the water channel aquaporin-4 (AQP4). 
AQP4 is the most abundant water 
channel in the brain and is concentrated 
in the astrocyte membranes that border 
 
Despite the drop in IgM protein production, IgM heavy
chain transcripts were not decreased in XBP-1–deficient
cells, suggesting that XBP-1 affected translation. Although
the mechanism is not yet clear, Ploegh suspects that XBP-1
might drive the expression of microRNAs that regulate
translation, similar to those that control gene expression during
neuronal development in worms and cell fate decisions in
developing hematopoietic cells. 
Electron micrograph of a mature plasma cell showing extensive 
endoplasmic reticulum.  Reproduced from Bosman et al. (1969. 
J. Exp. Med. 129:1029–1044).
 
the blood–brain barrier. The expression 
of this protein is increased in patients 
with epilepsy and certain brain tumors, 
probably accounting for the associated 
brain edema that can limit blood flow 
and deprive the brain of oxygen.
Lennon suspects that the 
consequences of the antibody’s binding to 
AQP4 in the brain are twofold. The binding 
might directly alter the function of the 
water channel, triggering swelling. The 
antibodies might also trigger complement 
activation, which could then initiate the 
robust inflammatory reaction that is 
characteristic of early NMO.
Aquaporins are also abundant in the 
kidney, where they are required for normal 
water retention and urine concentration. 
Indeed, the anti-AQP4 antibodies from the 
NMO patients reacted with kidney tissue. 
It remains a mystery why these patients do 
not develop renal abnormalities.
The authors now plan to test whether 
AQP4-specific antibodies can trigger an 
NMO-like disease in mice. In the meantime, 
they have shown that these antibodies 
provide a useful diagnostic tool to distinguish 
NMO patients from those with conventional 
MS, as the diseases call for distinct 
treatment strategies. 
Antibodies from patients with neuromyelitis 
optica bind to the water channel aquaporin-4 
(yellow) in brain tissue.
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